ROCKVILLE, Md., Dec. 08, 2021 (GLOBE NEWSWIRE) OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power.
Vote on Proposal to Increase Authorized Capital Adjourned and Rescheduled for November 3, 2021 The Company encourages all shareholders who have not yet.